Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder

Sertraline is one among several selective serotonin reuptake inhibitors (SSRIs) that exhibited improvement of language development in Autism Spectrum Disorder (ASD); however, the molecular mechanism has not been elucidated. A double blind, randomized, 6-month, placebo-controlled, clinical trial of l...

Descripción completa

Detalles Bibliográficos
Autores principales: Alolaby, Reem Rafik, Jiraanont, Poonnada, Durbin-Johnson, Blythe, Jasoliya, Mittal, Tang, Hiu-Tung, Hagerman, Randi, Tassone, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174723/
https://www.ncbi.nlm.nih.gov/pubmed/32346385
http://dx.doi.org/10.3389/fgene.2020.00308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174723/
https://www.ncbi.nlm.nih.gov/pubmed/32346385
http://dx.doi.org/10.3389/fgene.2020.00308

Ejemplares similares